Zepp Health (NYSE:ZEPP) Posts Earnings Results

Zepp Health (NYSE:ZEPP) announced its quarterly earnings data on Monday. The company reported ($0.03) EPS for the quarter, FiscalAI reports. Zepp Health had a negative return on equity of 14.78% and a negative net margin of 15.48%.The business had revenue of $85.17 million during the quarter.

Zepp Health Trading Down 5.7%

NYSE ZEPP opened at $15.29 on Wednesday. Zepp Health has a 12 month low of $2.13 and a 12 month high of $61.85. The company has a current ratio of 1.09, a quick ratio of 0.78 and a debt-to-equity ratio of 0.31. The stock has a 50 day moving average of $21.60 and a 200-day moving average of $32.37. The company has a market cap of $221.69 million, a PE ratio of -6.09 and a beta of 1.44.

Institutional Trading of Zepp Health

A number of large investors have recently added to or reduced their stakes in ZEPP. Ariose Capital Management Ltd bought a new position in shares of Zepp Health in the 3rd quarter valued at about $1,269,000. Trivest Advisors Ltd bought a new position in shares of Zepp Health during the 3rd quarter worth approximately $13,503,000. Keystone Investors PTE Ltd. bought a new position in shares of Zepp Health during the 3rd quarter worth approximately $4,811,000. UBS Group AG increased its holdings in shares of Zepp Health by 16,412.0% during the 3rd quarter. UBS Group AG now owns 181,302 shares of the company’s stock worth $8,300,000 after acquiring an additional 180,204 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd bought a new stake in Zepp Health in the 3rd quarter valued at $1,895,000. Institutional investors and hedge funds own 52.61% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Zepp Health in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Zepp Health has a consensus rating of “Hold” and a consensus target price of $64.37.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.